Suita, Japan

Xin Wu

This inventor holds 3 USPTO granted patents. Top assignees: Cancerstem Tech Inc., Ijunkai, Other. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Wu. Retrieved from https://idiyas.com/inventor/xin-wu-tkhlpny5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Suita, JP (2016 - 2018)
  • Nishinomiya, JP (2022)

Company Filing History:

goldMedal1 out of 1 
 
Cancerstem Tech Inc.
 patent
silverMedal1 out of 1 
 
Ijunkai
 patent
bronzeMedal2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2016-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xin Wu

Introduction

Xin Wu is a notable inventor based in Suita, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 3 patents, his work focuses on enhancing the efficacy of cancer therapies.

Latest Patents

One of Xin Wu's latest patents is a cancer stem cell growth inhibitor using miRNA. The purpose of this invention is to provide a nucleic acid medication for cancer treatment, capable of suppressing the growth of cancer stem cells and thus effectively treating cancer. The specific miRNAs identified, including hsa-miR-136-5p, hsa-miR-3065-3p, hsa-miR-4727-5p, hsa-miR-378g, hsa-miR-181a-5p, hsa-miR-362-5p, and hsa-miR-608, have shown remarkable growth inhibitory action on cancer stem cells, making them useful as a nucleic acid medication for various cancers. Another significant patent is an enhancer of the anti-tumor effect of anti-cancer agents. This invention aims to provide an agent that potentiates the antitumor effect of an anticancer agent by allowing efficient accumulation of the anticancer agent in tumor tissue. The administration of carbonate apatite with the anticancer agent allows for efficient accumulation in tumor tissue, dramatically enhancing the antitumor effect.

Career Highlights

Throughout his career, Xin Wu has worked with various organizations, including Cancerstem Tech Inc. His innovative approaches and dedication to cancer research have positioned him as a key figure in the field.

Collaborations

Xin Wu has collaborated with notable individuals such as Hirofumi Yamamoto and Masaki Mori. These partnerships have contributed to the advancement of his research and the development of effective cancer treatments.

Conclusion

Xin Wu's contributions to cancer treatment through his innovative patents highlight the importance of research in combating this disease. His work continues to inspire advancements in medical science and offers hope for improved cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…